Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies).
Teramoto T, Kobayashi M, Uno K, Takagi Y, Matsuoka O, Sugimoto M, Inoue S, Minami F, Baccara-Dinet MT.
Teramoto T, et al. Among authors: kobayashi m.
Am J Cardiol. 2016 Jul 1;118(1):56-63. doi: 10.1016/j.amjcard.2016.04.011. Epub 2016 Apr 21.
Am J Cardiol. 2016.
PMID: 27184170
Free article.
Clinical Trial.